Get In Touch

Global Intracranial Stents Market - Snapshot

The global intracranial stents market has expanded significantly over the last two decades, and the market has been characterized by technological innovation and increase in preference for intracranial stents for the treatment of intracranial stenosis and management of stroke. Rapid rise in the geriatric population, increase in incidence of chronic neurological diseases, and high research and development activities in the field of stroke management and chronic neurological diseases are major environmental factors that drive the intracranial stents market. However, tight budgetary constraints faced by intracranial stents manufacturers and healthcare service providers are key factors that, currently, restrain the market.

High demand for minimally-invasive procedures, availability of embolic devices, and rising prevalence of intracranial atherosclerosis disease across the world, due to increase in risk factors such as hypertension, diabetes, and obesity, are likely to drive the market during the forecast period. Technical advances, such as rapid innovation in the field of self-expanding stents and improvement in flexibility of the stents, are primary influences of the intracranial stents market. Increase in health care expenditure and expansion of the medical devices industry propel the intracranial stents market globally. Changing health care reforms, increase in government initiatives, and rise in the number of product manufacturers targeting the emerging regions are expected to drive the intracranial stents market in various regions during the forecast period.

The global intracranial stents market was valued at US$ 298.7 Mn in 2017 and is anticipated to reach US$ 705.5 Mn by 2026, expanding at a CAGR of 10.4% from 2018 to 2026. Increasing prevalence of chronic diseases in the geriatric population, favorable reimbursement scenario, and increasing government initiatives toward geriatrics are expected to boost the intracranial stents market during the forecast period.

intracranial-stents-market.jpg

The global intracranial stents market has been segmented based on product type, disease indication, end-user, and region. In terms of product type, the intracranial stents market has been divided into self-expanding stents, balloon expanding stents, and stent-assisted coil embolization. In terms of disease indication, the market has been segregated into intracranial stenosis and brain aneurysm. The self-expanding stents segment accounted for a prominent share of the market, in terms of revenue, in 2017. The segment is also expected to expand at a CAGR of 11.7% during the forecast period.

In terms of region, North America accounted for a leading share of the global intracranial stents market, in terms of revenue, followed by Europe. High prevalence of neurological diseases coupled with the presence of sophisticated healthcare infrastructure and rising per capita healthcare expenditure are boosting the market in the region. Moreover, strong research and development activities in the region promoting the development of new neurology devices have contributed to the significant market share held by the region in the global intracranial stents market. Contribution of revenue from the developed countries in Western Europe, such as the U.K., Germany, France, and Italy, is responsible for the prominent share held by Europe in the global market. The amplifying base of the target patient population, i.e., geriatric people (over the age of 65 years), is anticipated to drive the intracranial stents market in Europe during the forecast period.

The intracranial stents market in Asia Pacific is expected to expand at a significant pace due to developing healthcare infrastructure and increasing government support for people. Other regions, such as Middle East & Africa and Latin America, are expected to be lucrative markets for intracranial stents in the near future, due to the high rate of adoption of advanced medical devices coupled with the rapid expansion of the health care industry in these regions.

Prominent players operating in the global intracranial stents market include Penumbra, Inc., Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson Services, Inc., Terumo Corporation, and Cook Medical.

Increased Adoption of Advanced Technology in Healthcare Sector Drives Sales Avenues in Intracranial Stents Market

Intracranial stenting, which is also called as intracranial vessel stenting, refers to a minimally invasive procedure employed for the treatment of cerebral artery stenosis, a health condition in which the arteries supplying blood to the brain become narrowed. Patients with this health condition are at higher risk of stroke.

In recent few years, the healthcare sector across the globe is experiencing increased adoption of intracranial stents. This shift is on the back of many advantages of intracranial stents. Intracranial stents are a safe, effectual, and minimally invasive substitute to surgery. This is comparatively less invasive technique than the traditional open surgeries performed for the vascular malformation management. As a result, the patients go through fewer complications and relatively minimum hospital stay following intracranial stenting process. There is less blood loss in intracranial stenting procedures as compared to conventional surgical treatments available. Owing to all these factors, there is remarkable growth in acceptance of intracranial stents in the treatment of many tumors as well as vascular malformations, which are difficult to remove by surgery or involve high risk while performing surgery. This scenario depicts that the global intracranial stents market will experience promising expansion avenues in the forthcoming years.

Many players in the global intracranial stents market have experienced sudden drop in their sales during COVID-19 pandemic. In addition to this, majority of players have stopped their production activities. Therefore, vendors working in the global intracranial stents market are growing focus toward strategizing their business moves to deal with the recent COVID-19 pandemic. Many enterprises in the intracranial stents market are starting production activities with skeleton staff and following all the guidelines suggested by government authorities. Owing to this factor, the global intracranial stents market is expected to regain its all regular work in short period of time and show promising growth in the forthcoming years.

Global Intracranial Stents Market: Overview

This report on the global intracranial stents market analyzes the current and future prospects of the market. The report comprises a comprehensive executive summary, including a market snapshot that provides overall information of various segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market value in terms of US$ Mn for each segment for the period from 2016 to 2026, considering the macro and micro environmental factors. Growth rates for each segment within the global intracranial stents market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining the market and future opportunities has been provided in the market overview section. The report also provides insights into the key trends of the intracranial stents market. Market value in terms of US$ Mn for the period between 2016 and 2026 along with the compound annual growth rate (CAGR %) from 2018 to 2026 are provided for all the segments, considering 2017 as the base year. The year-on-year growth of the global intracranial stents market for each segment is also reflected. Additionally, market-related factors such as increasing prevalence of chronic disease, rising geriatric population, favorable government policies, developing healthcare infrastructure in emerging countries, and historical year-on-year growth have been taken into consideration while estimating the market size.

Global Intracranial Stents Market: Key Segments

The global intracranial stents market has been segmented based on product type, disease indication, end-user, and region. In terms of product type, the intracranial stents market has been divided into self-expanding stents, balloon expanding stents and stent-assisted coil embolization. In terms of disease indication, the market has been segregated into intracranial stenosis and brain aneurysm. In terms of end-user, the market has been classified into, hospitals, ambulatory surgical centers, and others

Global Intracranial Stents Market: Regional Outlook

In terms of region, the global intracranial stents market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Additionally, the regions have been further segmented into major countries in each of the regions. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Australia & New Zealand, Japan, India, Brazil, GCC, South Africa, and Mexico.

Companies Mentioned in Report

The report also profiles major players in the intracranial stents market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Penumbra, Inc., Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson Services, Inc., Terumo Corporation, and Cook Medical.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

The global intracranial stents market has been segmented as follows:

Product Type

  • Tea Lights
  • Votive
  • Pillars
  • Birthday Candle
  • Cartridge Candle
  • Wax Filled Container Candles
  • Others

Disease Indication

  • Intracranial Stenosis
  • Brain Aneurysm

End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Australia & New Zealand
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Section 1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

Section 2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Research Methodology

Section 3. Executive Summary
3.1. Global Intracranial Stents Market Snapshot
3.2. Global Intracranial Stents Market Share Analysis, by Region, 2017

Section 4. Market Overview
4.1. Global Intracranial Stents Market Taxonomy
4.2. Global Intracranial Stents Market Value (US$ Mn) Forecast, 2016–2026
4.3. Global Intracranial Stents Market: Market Outlook

Section 5. Global Intracranial Stents Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
       5.2.1. Strategic acquisitions
       5.2.2. Less invasive than conventional open surgery
       5.2.3. Rising number of stroke patients
       5.2.4. Growth in global geriatric population
5.3. Restraints
       5.3.1. Post embolization syndrome
       5.3.2 Rise in cost of embolization coils
       5.3.3. Lack of skilled personnel
5.4. Development of new materials for catheterization and embolization

Section 6. Global Intracranial Stents Market Analysis, by Product Type
6.1. Key Findings
6.2. Introduction
6.3. Global Intracranial Stents Market Value Share Analysis, by Product Type
6.4. Global Intracranial Stents Market Forecast, by Product Type
6.5. Global Intracranial Stents Market Analysis, by Product Type
       6.5.1. Self-expanding Stents
       6.5.2. Balloon Expanding Stents
       6.5.3. Stent-assisted Coil Embolization

Section 7. Global Intracranial Stents Market Analysis, by Disease Indication
7.1. Key Findings
7.2. Introduction
7.3. Global Intracranial Stents Market Value Share Analysis, by Disease Indication
7.4. Global Intracranial Stents Market Forecast, by Disease Indication
7.5. Global Intracranial Stents Market Analysis, by Disease Indication
       7.5.1. Intracranial Stenosis
       7.5.2. Brain Aneurysm

Section 8. Global Intracranial Stents Market Analysis, by End-user
8.1. Key Findings
8.2. Introduction
8.3. Global Intracranial Stents Market Value Share Analysis, by End-user
8.4. Global Intracranial Stents Market Forecast, by End-user
8.5. Global Intracranial Stents Market Analysis, by End-user
       8.5.1. Hospitals
       8.5.2. Ambulatory Surgery Centers
       8.5.3. Others

Section 9. Global Intracranial Stents Market Analysis, by Region
9.1. Global Intracranial Stents Market Value Share Analysis, by Region
9.2. Global Intracranial Stents Market Forecast, by Region

Section 10. North America Intracranial Stents Market Analysis, by Region
10.1. North America Intracranial Stents Market Overview
10.2. North America Intracranial Stents Market Attractiveness Analysis, by Country
10.3. North America Intracranial Stents Market Value Share Analysis, by Product Type
10.4. North America Intracranial Stents Market Forecast, by Product Type
10.5. North America Intracranial Stents Market Value Share Analysis, by Disease Indication
10.6. North America Intracranial Stents Market Forecast, by Disease Indication
10.7. North America Intracranial Stents Market Value Share Analysis, by End-user
10.8. North America Intracranial Stents Market Forecast, by End-user
10.9. North America Intracranial Stents Market Value Share Analysis, by Country
       10.10.1. U.S.
       10.10.2. Canada

Section 11. Europe Intracranial Stents Market Analysis, by Region
11.1. Europe Intracranial Stents Market Overview
11.2. Europe Intracranial Stents Market Attractiveness Analysis, by Country/Sub-region
11.3. Europe Intracranial Stents Market Value Share Analysis, by Product Type
11.4. Europe Intracranial Stents Market Forecast, by Product Type
11.5. Europe Intracranial Stents Market Value Share Analysis, by Disease Indication
11.6. Europe Intracranial Stents Market Forecast, by Disease Indication
11.7. Europe Intracranial Stents Market Value Share Analysis, by End-user
11.8. Europe Intracranial Stents Market Forecast, by End-user
11.9. Europe Intracranial Stents Market Value Share Analysis, by Country/Sub-region
11.10. Europe Intracranial Stents Market Forecast, by Country/Sub-region
       11.10.1. Germany
       11.10.2. U.K.
       11.10.3. France
       11.10.4. Spain
       11.10.5. Italy
       11.10.6. Rest of Europe

Section 12. Asia Pacific Intracranial Stents Market Analysis, by Region
12.1. Asia Pacific Intracranial Stents Market Overview
12.2. Asia Pacific Intracranial Stents Market Attractiveness Analysis, by Country/Sub-region
12.3. Asia Pacific Intracranial Stents Market Value Share Analysis, by Product Type
12.4. Asia Pacific Intracranial Stents Market Forecast, by Product Type
12.5. Asia Pacific Intracranial Stents Market Value Share Analysis, by Disease Indication
12.6. Asia Pacific Intracranial Stents Market Forecast, by Disease Indication
12.7. Asia Pacific Intracranial Stents Market Value Share Analysis, by End-user
12.8. Asia Pacific Intracranial Stents Market Forecast, by End-user
12.9. Asia Pacific Intracranial Stents Market Value Share Analysis, by Country
12.10. Asia Pacific Intracranial Stents Market Forecast, by Country
       12.10.1. China
       12.10.2. Japan
       12.10.3. India
       12.10.4. Australia & New Zealand
       12.10.5. Rest of APAC

Section 13. Latin America Intracranial Stents Market Analysis, by Region
13.1. Latin America Intracranial Stents Market Overview
13.2. Latin America Intracranial Stents Market Attractiveness Analysis, by Country/Sub-region
13.3. Latin America Intracranial Stents Market Value Share Analysis, by Product Type
13.4. Latin America Intracranial Stents Market Forecast, by Product Type
13.5. Latin America Intracranial Stents Market Value Share Analysis, by Disease Indication
13.6. Latin America Intracranial Stents Market Forecast, by Disease Indication
13.7. Latin America Intracranial Stents Market Value Share Analysis, by End-user
13.8. Latin America Intracranial Stents Market Forecast, by End-user
13.9. Latin America Intracranial Stents Market Value Share Analysis, by Country/Sub-region
13.10. Latin America Intracranial Stents Market Forecast, by Country/Sub-region
       13.10.1. Brazil
       13.10.2. Mexico
       13.10.3. Rest of LATAM

Section 14. Middle East & Africa Intracranial Stents Market Analysis, by Region
14.1. Middle East & Africa Intracranial Stents Market Overview
14.2. Middle East & Africa Intracranial Stents Market Attractiveness Analysis, by Country/Sub-region
14.3. Middle East & Africa Intracranial Stents Market Value Share Analysis, by Product Type
14.4. Middle East & Africa Intracranial Stents Market Forecast, by Product Type
14.5. Middle East & Africa Intracranial Stents Market Value Share Analysis, by Disease Indication
14.6. Middle East & Africa Intracranial Stents Market Forecast, by Disease Indication
14.7. Middle East & Africa Intracranial Stents Market Value Share Analysis, by End-user
14.8. Middle East & Africa Intracranial Stents Market Forecast, by End-user
14.9. Middle East & Africa Intracranial Stents Market Value Share Analysis, by Country/Sub-region
14.10. Middle East & Africa Intracranial Stents Market Forecast, by Country/Sub-region
       14.10.1. GCC
       14.10.2. South Africa
       14.10.3. Rest of Middle East & Africa

Section 15. Company Profiles
15.1. Competitive Matrix
15.2. Company Profiles
       15.2.1. Penumbra, Inc.
                 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                 15.2.1.2. Financial Overview
                 15.2.1.3. Product Portfolio
                 15.2.1.4. SWOT Analysis
                 15.2.1.5. Strategic Overview
       15.2.2. Medtronic plc
                 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                 15.2.2.2. Financial Overview
                 15.2.2.3. Product Portfolio
                 15.2.2.4. SWOT Analysis
                 15.2.2.5. Strategic Overview
       15.2.3. Stryker Corporation
                 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                 15.2.3.2. Financial Overview
                 15.2.3.3. Product Portfolio
                 15.2.3.4. SWOT Analysis
                 15.2.3.5. Strategic Overview
       15.2.4. Boston Scientific Corporation
                 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                 15.2.4.2. Financial Overview
                 15.2.4.3. Product Portfolio
                 15.2.4.4. SWOT Analysis
                 15.2.4.5. Strategic Overview
       15.2.5. Johnson & Johnson Services, Inc.
                 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                 15.2.5.2. Financial Overview
                 15.2.5.3. Product Portfolio
                 15.2.5.4. SWOT Analysis
                 15.2.5.5. Strategic Overview
       15.2.6. Terumo Corporation
                 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                 15.2.6.2. Financial Overview
                 15.2.6.3. Product Portfolio
                 15.2.6.4. SWOT Analysis
                 15.2.6.5. Strategic Overview
       15.2.7. Cook Medical
                 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                 15.2.7.2. Financial Overview
                 15.2.7.3. Product Portfolio
                 15.2.7.4. SWOT Analysis
                 15.2.7.5. Strategic Overview

List of Tables

Table 01: Global Intracranial Stents Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 02: Global Intracranial Stents Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 03: Global Intracranial Stents Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 04: Global Intracranial Stents Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 05: North America Intracranial Stents Market Value (US$ Mn) Forecast, by Product Type, 2018–2026
Table 06: North America Intracranial Stents Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2026
Table 07: North America Intracranial Stents Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 08: North America Intracranial Stents Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 09: Europe Intracranial Stents Market Value (US$ Mn) Forecast, by Product Type, 2018–2026
Table 10: Europe Intracranial Stents Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2026
Table 11: Europe Intracranial Stents Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 12: Europe Intracranial Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 13: Asia Pacific Intracranial Stents Market Value (US$ Mn) Forecast, by Product Type, 2018–2026
Table 14: Asia Pacific Intracranial Stents Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2026
Table 15: Asia Pacific Intracranial Stents Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 16: Asia Pacific Intracranial Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 17: Latin America Intracranial Stents Market Value (US$ Mn) Forecast, by Product Type, 2018–2026
Table 18: Latin America Intracranial Stents Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2026
Table 19: Latin America Intracranial Stents Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 20: Latin America Intracranial Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 21: Middle East & Africa Intracranial Stents Market Value (US$ Mn) Forecast, by Product Type, 2018–2026
Table 22: Middle East & Africa Intracranial Stents Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2026
Table 23: Middle East & Africa Intracranial Stents Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 24: Middle East & Africa Intracranial Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 25: Business Segments & Product Overview of Penumbra, Inc.
Table 26: Business Segments & Product Overview of Medtronic plc
Table 27: Business Segments & Product Overview of Stryker Corporation
Table 28: Business Segments & Product Overview of Boston Scientific Corporation
Table 29: Business Segments & Product Overview of Johnson & Johnson Services, Inc.
Table 30: Business Segments & Product Overview of Terumo Corporation
Table 31: Business Segments & Product Overview of Cook Medical

List of Figures

Figure 01: Global Intracranial Stents Market Snapshot
Figure 02: Global Intracranial Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
Figure 04: Global Intracranial Stents Market Value Share by Disease Indication (2017)
Figure 06: Global Intracranial Stents Market Value Share by Region (2017)
Figure 03: Global Intracranial Stents Market Value Share by Product Type (2017)
Figure 05: Global Intracranial Stents Market Value Share by End-user (2017)
Figure 07: Global Intracranial Stents Market Value Share, by Product Type, 2017 and 2026
Figure 08: Global Intracranial Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026, by Self-expanding Stents
Figure 09: Global Intracranial Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026, by Balloon Expanding Stents
Figure 10: Global Intracranial Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026, by Stent-assisted Coil Embolization
Figure 11: Global Intracranial Stents Market Value Share, by Disease Indication, 2017 and 2026
Figure 12: Global Intracranial Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026, by Intracranial Stenosis
Figure 13: Global Intracranial Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026, by Brain Aneurysm
Figure 14: Global Intracranial Stents Market Value Share, by End-user, 2017 and 2026
Figure 15: Global Intracranial Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2016–2026
Figure 16: Global Intracranial Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ambulatory Surgery Centers, 2016–2026
Figure 17: Global Intracranial Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026, by Others
Figure 18: Global Intracranial Stents Market Value Share, by Region, 2017 and 2026
Figure 19: North America Intracranial Stents Market Value (US$ Mn) Forecast, 2016–2026
Figure 20: North America Market Attractiveness Analysis, by Country
Figure 21: North America Intracranial Stents Market Value Share Analysis, by Product Type, 2017 and 2026
Figure 22: North America Intracranial Stents Market Value Share Analysis, by Disease Indication, 2017 and 2026
Figure 23: North America Intracranial Stents Market Value Share Analysis, by End-user, 2017 and 2026
Figure 24: North America Intracranial Stents Market Value Share Analysis, by Country, 2017 and 2026
Figure 25: Europe Intracranial Stents Market Value (US$ Mn) Forecast, 2016–2026
Figure 26: Europe Market Attractiveness Analysis, by Country/Sub-region
Figure 27: Europe Intracranial Stents Market Value Share Analysis, by Product Type, 2017 and 2026
Figure 28: Europe Intracranial Stents Market Value Share Analysis, by Disease Indication, 2017 and 2026
Figure 29: Europe Intracranial Stents Market Value Share Analysis, by End-user, 2017 and 2026
Figure 30: Europe Intracranial Stents Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 31: Asia Pacific Intracranial Stents Market Value (US$ Mn) Forecast, 2016–2026
Figure 32: Asia Pacific Market Attractiveness Analysis, by Country/Sub-region
Figure 33: Asia Pacific Intracranial Stents Market Value Share Analysis, by Product Type, 2017 and 2026
Figure 34: Asia Pacific Intracranial Stents Market Value Share Analysis, by Disease Indication, 2017 and 2026
Figure 35: Asia Pacific Intracranial Stents Market Value Share Analysis, by End-user, 2017 and 2026
Figure 36: Asia Pacific Intracranial Stents Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 37: Latin America Intracranial Stents Market Value (US$ Mn) Forecast, 2016–2026
Figure 38: Latin America Market Attractiveness Analysis, by Country/Sub-region
Figure 39: Latin America Intracranial Stents Market Value Share Analysis, by Product Type, 2017 and 2026
Figure 40: Latin America Intracranial Stents Market Value Share Analysis, by Disease Indication, 2017 and 2026
Figure 41: Latin America Intracranial Stents Market Value Share Analysis, by End-user, 2017 and 2026
Figure 42: Latin America Intracranial Stents Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 43: Middle East & Africa Intracranial Stents Market Value (US$ Mn) Forecast, 2016–2026
Figure 44: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region
Figure 45: Middle East & Africa Intracranial Stents Market Value Share Analysis, by Product Type, 2017 and 2026
Figure 46: Middle East & Africa Intracranial Stents Market Value Share Analysis, by Disease Indication, 2017 and 2026
Figure 47: Middle East & Africa Intracranial Stents Market Value Share Analysis, by End-user, 2017 and 2026
Figure 48: Middle East & Africa Intracranial Stents Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 49: Penumbra, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 50: Penumbra, Inc. Breakdown of Net Sales, by Region, 2017
Figure 51: Penumbra, Inc. Breakdown of Net Sales, by Business Segment, 2017
Figure 52: Penumbra, Inc. Research & Development Cost (US$ Mn), 2015–2017
Figure 53: Medtronic plc Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2017
Figure 54: Medtronic plc Marketing & Sales and R&D Expenses, 2016–2017
Figure 55: Medtronic plc Breakdown of Net Sales, by Business Segment, 2017
Figure 56: Medtronic plc Breakdown of Net Sales, by Region, 2017
Figure 57: Stryker Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 58: Stryker Corporation Breakdown of Net Sales (%), by Region, 2017
Figure 59: Stryker Corporation Breakdown of Net Sales (%), by Business Segment, 2017
Figure 60: Boston Scientific Corporation Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2017
Figure 61: Boston Scientific Corporation R&D Expenses, 2016–2017
Figure 62: Boston Scientific Corporation Breakdown of Net Sales, by Business Segment, 2017
Figure 63: Figure Boston Scientific Corporation Breakdown of Net Sales, by Region, 2017
Figure 64: Johnson & Johnson Services, Inc. Revenue (US$ Bn) & Y-o-Y Growth (%), 2014–2017
Figure 65: Johnson & Johnson Services, Inc. Breakdown of Net Sales of Medical Devices Segment, by Region, 2017
Figure 66: Johnson & Johnson Services, Inc. Breakdown of Net Sales, by Business Segment, 2017
Figure 67: Johnson & Johnson Services, Inc. Research & Development Cost, 2015 – 2017 (US$ Bn)
Figure 68: Terumo Corporation Breakdown of Net Sales, by Region, 2017
Figure 69: Terumo Corporation Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2017

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Intracranial Stents Market